Transplant Medicine encompasses the medical management of patients undergoing organ or tissue transplantation. KKI operates one of the nation’s largest integrated transplant programs across Arizona, Florida, and Minnesota. Their teams perform over 2,000 solid-organ and bone marrow transplants annually, leveraging deep expertise and a multidisciplinary approach to deliver outstanding patient outcomes.
This specialty is essential for treating end-stage organ failure (heart, kidney, liver, lung, pancreas, bone marrow, face, hand, or larynx). Transplant medicine helps restore function and improve quality of life where long-term survival depends on replacing damaged organs.
KKI’s care model is highly collaborative and whole person centered. Multiple specialties—such as cardiology, nephrology, hepatology, reconstructive surgery, infectious disease, and psychiatry—work together to address medical, nutritional, psychological, financial, and logistical needs of transplant patients
KKI’s transplant portfolio includes both adult and pediatric services in the following areas:
Kidney & Pancreas
Heart
Liver
Lung
Bone Marrow
Pancreas
Living-Donor
Hand & Face
Larynx & Trachea
These programs reflect KKI’s clinical depth and innovation in both routine and rare transplant procedures.
Organ recipients require lifelong anti-rejection medications to prevent immunological graft rejection:
Regimens often begin with induction therapy (e.g., basiliximab or ATG), followed by maintenance immunosuppression (e.g. tacrolimus, mycophenolate, sirolimus, prednisone).
Anti-rejection drugs may lead to side effects like high blood pressure, elevated cholesterol, infections, and diabetes—necessitating careful monitoring of immunosuppressant blood levels.
Key prevention and monitoring strategies include:
Watching for infections or malignancies, which rise with immunosuppression.
Avoiding drug interactions (e.g., grapefruit juice, certain antifungals) that may elevate tacrolimus or sirolimus levels.
Ensuring medication adherence; missed doses remain the leading cause of graft failure.
KKI’s integrated care model yields top-tier outcomes—fast access to transplantation, high rates of graft acceptance, and long-term survival. Their blend of clinical volume, research, and personalized care leads to results often better than national averages.
Transplant Research Center and Transplant Immunology Program lead interdisciplinary trials and innovations (e.g., reducing antibody-mediated rejection, immunologic tolerance, and regenerative approaches).
Kidney & Pancreas Program focuses on reducing disease recurrence, expanding living-donor transplantation, and improving cardiovascular outcomes.
Regenerative medicine and bioengineering research intersect with transplant medicine to explore future organ restoration methods.
Transplant medicine at KKI supports 24/7 physician referrals across all organ types, with clear pathways for consultation and referral via physician services at each campus.
